Roivant Sciences Ltd. (ROIV) Social Stream
ROIVANT SCIENCES LTD (ROIV) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ROIV.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-16 | 6 | $15 | $10 | $12.2 | $11.27 | 8.25% |
| 2021-12-22 | 6 | $16 | $11 | $13.4 | $11.27 | 18.9% |
| 2022-02-15 | 6 | $16 | $11 | $14 | $11.27 | 24.22% |
| 2022-05-13 | 6 | $16 | $11 | $14.2 | $11.27 | 26% |
| 2022-05-22 | 7 | $16 | $3.7 | $12.45 | $11.27 | 10.47% |
| 2022-05-23 | 8 | $16 | $6 | $12.833 | $11.27 | 13.87% |
| 2022-05-26 | 8 | $16 | $6 | $12.714 | $11.27 | 12.81% |
| 2022-08-16 | 8 | $16 | $7 | $12.571 | $11.27 | 11.54% |
| 2022-09-28 | 8 | $15 | $6 | $11 | $11.27 | -2.4% |
| 2022-10-27 | 8 | $15 | $6 | $10.5 | $11.27 | -6.83% |
| 2022-11-02 | 6 | $15 | $7 | $10.75 | $11.27 | -4.61% |
| 2022-11-15 | 8 | $15 | $7 | $10.75 | $11.27 | -4.61% |
| 2022-12-12 | 9 | $19 | $8 | $12 | $11.27 | 6.48% |
| 2022-12-19 | 9 | $19 | $8 | $12.25 | $11.27 | 8.7% |
| 2022-12-27 | 9 | $19 | $9 | $12.75 | $11.27 | 13.13% |
| 2023-01-05 | 9 | $19 | $9 | $13.125 | $11.27 | 16.46% |
| 2023-02-14 | 9 | $19 | $10 | $13.25 | $11.27 | 17.57% |
| 2023-03-16 | 9 | $19 | $10 | $13.375 | $11.27 | 18.68% |
| 2023-03-17 | 9 | $19 | $10 | $13.5 | $11.27 | 19.79% |
| 2023-05-18 | 8 | $19 | $10 | $13.875 | $11.27 | 23.11% |
| 2023-06-08 | 8 | $19 | $10 | $13.687 | $11.27 | 21.45% |
| 2023-06-23 | 9 | $23 | $10 | $14.25 | $11.27 | 26.44% |
| 2023-06-28 | 9 | $23 | $11 | $14.875 | $11.27 | 31.99% |
| 2023-06-29 | 9 | $23 | $11 | $15.5 | $11.27 | 37.53% |
| 2023-08-15 | 9 | $23 | $11 | $15.75 | $11.27 | 39.75% |
| 2023-10-12 | 10 | $23 | $12 | $16.111 | $11.27 | 42.95% |
| 2023-10-28 | 11 | $23 | $12 | $16.2 | $11.27 | 43.74% |
| 2023-11-14 | 10 | $23 | $12 | $16.125 | $11.27 | 43.08% |
| 2023-11-15 | 10 | $23 | $12 | $16 | $11.27 | 41.97% |
| 2023-11-27 | 10 | $23 | $11 | $16 | $11.27 | 41.97% |
The Trend in the Analyst Price Target
Over the past 25 months, ROIV's average price target has gone up $3.8.
ROIV reports an average of 61.33% for its upside potential over the past 46 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-10 | 9 | 19 | 10 | 13.250 | 9.820 | 34.93% |
| 2023-08-15 | 9 | 23 | 12 | 15.875 | 10.970 | 44.71% |
| 2023-09-27 | 10 | 23 | 12 | 16.111 | 13.190 | 22.15% |
| 2023-10-02 | 10 | 23 | 12 | 16.111 | 10.515 | 53.22% |
| 2023-10-28 | 11 | 23 | 12 | 16.444 | 8.380 | 96.23% |
ROIV Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.22 | 8 | 0 | 1 | 0 | 0 | 9 |
The Trend in the Broker Recommendations
ROIV's average broker recommendation rating worsened by 0.2 over the prior 48 weeks.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ROIV as an investment opportunity.
- ROIVANT SCIENCES LTD's average analyst price target is greater than 757.64% of all US stocks.
- ROIV has a lower variance in analysts' estimates than -3297.29% of all US stocks.
- In terms of how ROIVANT SCIENCES LTD fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is greater than 1061.28% of that group.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, ROIVANT SCIENCES LTD's number of analysts covering the stock is higher than 2602.97% of them.
Stocks similar to ROIVANT SCIENCES LTD in the Pharmaceutical Products industry regarding analyst recommendations and price targets are LYEL, AMLX, and SWTX.
View All Top Stocks by Price Target
Is ROIV a Buy, Hold or Sell? See the POWR Ratings now!